Cefixime Capsules, 400 mg, 50-count bottles, Rx only, Manufactured by: Alkem Laboratories Ltd., M...

FDA Recall #D-0359-2022 — Class II — December 21, 2021

Recall #D-0359-2022 Date: December 21, 2021 Classification: Class II Status: Terminated

Product Description

Cefixime Capsules, 400 mg, 50-count bottles, Rx only, Manufactured by: Alkem Laboratories Ltd., Mumbai, India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ, NDC 67877-584-50

Reason for Recall

Failed impurities/degradation specifications

Recalling Firm

Ascend Laboratories, LLC — Parsippany, NJ

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

42,698 bottles

Distribution

USA nationwide.

Code Information

Lot #: 20140293, Exp Dec 2021; 20141525, 20141526, 20141527, Exp Mar 2022; 20143019, 20143020, 20143021, 20143022, Exp July 2022; 20144759, 20144760, 20144761, Exp Nov 22

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated